AR-A014418 (Synonyms: AR 0133418; GSK 3β inhibitor VIII; AR 014418)
目录号: PL01509 纯度: ≥99%
CAS No. :487021-52-3
商品编号 规格 价格 会员价 是否有货 数量
PL01509-5mg 5mg ¥618.18 请登录
PL01509-10mg 10mg ¥741.82 请登录
PL01509-50mg 50mg ¥2472.73 请登录
PL01509-100mg 100mg ¥4327.27 请登录
PL01509-200mg 200mg 询价 询价
PL01509-500mg 500mg 询价 询价
PL01509-10mM*1mLinDMSO 10mM*1mLinDMSO ¥680.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
AR-A014418
中文别名
AR-A014418 抑制剂;N-(4-甲氧基苄基)-N'-(5-硝基-1,3-噻唑-2-基)脲;N-(4-甲氧基苄基)-N-(5-硝基-1,3-噻唑-2-基)脲;茚草酮;GSK-3BETA 抑制剂 VIII
英文名称
AR-A014418
英文别名
AR-A014418;GSK-3β Inhibitor VIII;N-[(4-Methoxyphenyl)methyl]-N'-(5-nitro-2-thiazolyl)urea;N-[(4-Methoxyphenyl)Methyl]-N'-(5-nitro-thiazol-2-yl)urea;AR-AO 14418;1-[(4-methoxyphenyl)methyl]-3-(5-nitro-1,3-thiazol-2-yl)urea;GSK3β Inhibitor VIII;SN 4521;1q5k;AR 0133418;AR 014418;GSK 3β inhibitor;GSK-3 Inhibitor VIII;GSK-3beta Inhibitor VIII;Kinome_1268;N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea;N-(4-Methoxybenzyl)-N′-(5-nitro-1,3-thiazol-2-yl)urea;GSK 3B Inhibitor VIII;GSK 3beta inhibitor VIII;1-(4-methoxybenzyl)-3-(5-nitrothiazol-2-yl)urea;GSK-3;A Inhibitor VIII;87KSH90Q6D;AK175829;InSolution™ GSK-3beta Inhibitor VIII;C12H12N4O4S;N-(4-Methoxybenzyl)-N′-(5-nitro-1,3-thiazol-2-yl)urea
Cas No.
487021-52-3
分子式
C12H12N4O4S
分子量
308.31
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
AR-A014418 是一种有效,选择性,ATP 竞争性的 GSK3β 抑制剂 (IC50=104 nM; Ki=38 nM)。
生物活性
AR-A014418 is a potent, selective and ATP-competitive GSK3β inhibitor (IC 50 =104 nM; K i =38 nM).
性状
Solid
IC50 & Target[1][2]
GSK-3β 104 nM (IC50)
体外研究(In Vitro)
AR-A014418 blocks the phosphorylation of tau at a GSK3-specific site (Ser-396) in 3T3 fibroblasts expressing human four-repeat tau protein, with an IC50 of 2.7 μM, and protects cultured N2A cells from death cuased by PI3K/PKB pathway blockage. AR-A014418 also shows inhibitory effect on neurodegeneration mediated by beta-amyloid peptide in hippocampal slices. AR-A014418 decreases neuroendocrine markers and suppresses neuroblastoma cell growth in NGP and SH-5Y-SY cells. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
AR-A014418 (0-4 mg/kg, i.p.) delays the onset of symptoms, enhances motor activity, blocks disease progression, and postpons the endpoint of the disease in ALS mouse model with the G93A mutant human SOD1. Furthermore, AR-A014418 suppresses acetic acid- and formalin-induced nociception in mice via modulating NMDA and metabotropic receptor signaling as well as TNF-α and IL-1β transmission in the spinal cord. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Bhat R, Xue Y, Berg S, Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem. 2003 Nov 14;278(46):45937-45.
[2]. Carter YM, et al. Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth. Cancer Biol Ther. 2014 May;15(5):510-5.
溶解度数据
In Vitro: DMSO : ≥ 100 mg/mL (324.35 mM)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2